Correlation Between Biomarin Pharmaceutical and AnaptysBio
Can any of the company-specific risk be diversified away by investing in both Biomarin Pharmaceutical and AnaptysBio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomarin Pharmaceutical and AnaptysBio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomarin Pharmaceutical and AnaptysBio, you can compare the effects of market volatilities on Biomarin Pharmaceutical and AnaptysBio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomarin Pharmaceutical with a short position of AnaptysBio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomarin Pharmaceutical and AnaptysBio.
Diversification Opportunities for Biomarin Pharmaceutical and AnaptysBio
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Biomarin and AnaptysBio is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Biomarin Pharmaceutical and AnaptysBio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AnaptysBio and Biomarin Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomarin Pharmaceutical are associated (or correlated) with AnaptysBio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AnaptysBio has no effect on the direction of Biomarin Pharmaceutical i.e., Biomarin Pharmaceutical and AnaptysBio go up and down completely randomly.
Pair Corralation between Biomarin Pharmaceutical and AnaptysBio
Given the investment horizon of 90 days Biomarin Pharmaceutical is expected to generate 0.2 times more return on investment than AnaptysBio. However, Biomarin Pharmaceutical is 4.92 times less risky than AnaptysBio. It trades about -0.21 of its potential returns per unit of risk. AnaptysBio is currently generating about -0.1 per unit of risk. If you would invest 7,013 in Biomarin Pharmaceutical on August 27, 2024 and sell it today you would lose (504.00) from holding Biomarin Pharmaceutical or give up 7.19% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biomarin Pharmaceutical vs. AnaptysBio
Performance |
| Timeline |
| Biomarin Pharmaceutical |
| AnaptysBio |
Biomarin Pharmaceutical and AnaptysBio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biomarin Pharmaceutical and AnaptysBio
The main advantage of trading using opposite Biomarin Pharmaceutical and AnaptysBio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomarin Pharmaceutical position performs unexpectedly, AnaptysBio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnaptysBio will offset losses from the drop in AnaptysBio's long position.| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
| AnaptysBio vs. Crinetics Pharmaceuticals | AnaptysBio vs. Rhythm Pharmaceuticals | AnaptysBio vs. Kura Oncology | AnaptysBio vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |